- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01935271
Nutritional Supplementation and Muscle Health: A Pilot Study on Immune Function
The ability of older adults to improve their muscle strength through exercise training appears related to how well their immune system functions. Thus, a nutritional supplement which improves immune function could theoretically boost strength gained for older adults from exercise. The purpose of this pilot study is to determine if a nutritional supplement has any effect on immune function.
Veterans (age 60-80 yrs, N=12) be randomized in a double-blind placebo-controlled fashion to consume supplement or placebo for four weeks. After two weeks of consumption, subjects will be treated with a vaccine for tetanus, diphtheria, and pertussis. Blood will be drawn from each subject before and after vaccination to determine the effects of the supplement on immune response to vaccination. Additionally, subjects will undergo blood draw and muscle biopsy before and after two weeks of supplementation to determine the effects of supplementation on other measures of immune function (e.g. cytokine and growth factor levels). This is an important issue due to the serious health consequences associated with muscle loss in older adults and the need for improved strategies for rehabilitation.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Arkansas
-
Little Rock, Arkansas, United States, 72205
- Central Arkansas Veterans Healthcare System
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Veteran
- Age 60-80 years
- Body Mass Index of 18.5 - 29.9 kg/m2
Exclusion Criteria:
- Participating in any other research study involving an intervention
- Smokes tobacco products
- Pains, tightness or pressure in chest during physical activity
- Participated in a weight-lifting targeting the thighs in last 3 months
- Problems walking or exercising with both legs
- Taking heparin, plavix / clopidogrel, or coumadin / warfarin
- Allergic to lidocaine
- Significant problem with fainting
- Allergic to vaccination
- Tetanus/diptheria/pertussis vaccine in previous two years
- Seizure in past 3 months
- Guillain-Barre Syndrome in past 3 months
- Enrolled in another interventional study
- Metastatic cancer or undergoing chemotherapy
- Cerebral aneurysm or intracranial bleed in past year
- End-stage congestive heart failure
- Unstable abdominal or thoracic aortic aneurysm
- Renal disease requiring dialysis
- Acute retinal hemorrhage or ophthalmologic surgery in past 3 months
- Bone fractures in the pelvis, legs, or feet in the last 3 months
- Hernia that causes pain during physical activity
- Myocardial infarction or cardiac surgery in past 3 months
- Pulmonary embolism or deep venous thrombosis in past 3 months
- Proliferative diabetic retinopathy or severe nonproliferative retinopathy
- Active suicidality or suicidal ideation
- Systemic bacterial infection
- Taking aspirin (in any form) and unable/unwilling to discontinue
- Unwilling to halt concurrent use of amino acid or protein supplements
- Unwilling to halt new use of nutritional supplements
- Unwilling to maintain current normal diet
- Encephalopathy in past 7 days
- Active oral or genital herpes
- Current use of appetite stimulants
- Current treatment for mania or bipolar disorder or taking lithium
- Diagnosis of a significant cognitive deficit
- Untreated severe aortic stenosis
- Uncontrolled diabetes mellitus
- Uncontrolled hypertension or hypotension (>160/100, <100 systolic)
- Uncontrolled malignant cardiac arrhythmia
- Unstable angina (at rest or increased pattern in past month)
- Allergic to latex or tape
- Bleeding or clotting disorders
- Taking any nonsteroidal anti-inflammatories and unable to discontinue use
- Taking certain supplements and unable or unwilling to discontinue use
- Significant problems with chronic pain
- Uncontrolled asthma or allergies
- Taking lactulose, nitrates plus hypertension medications, or Viagra
- Liver cirrhosis or other severe liver disease
- History of peripheral artery disease
- Steroid or androgen use in past 3 months
- Other physician judgment
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Muscle Armor Supplement
Treatment with a commercially available over the counter nutritional supplement
|
|
Placebo Comparator: Placebo
Sugar-based placebo drink mix
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in antibody titer to tetanus, diptheria, pertussis antigen post-vaccination.
Time Frame: Baseline, 1 and 2 weeks post-vaccination
|
The study will randomize subjects to consume supplement or placebo for 4-weeks.
After two weeks of consumption, subjects will be vaccinated against tetanus, pertussis, and diphtheria.
Blood will be drawn before and at two time points after vaccination.
Change in antibody titer against the vaccine antigens will be calculated.
A comparison between groups will determine if supplementation improves the antibody response to vaccination.
|
Baseline, 1 and 2 weeks post-vaccination
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in gene expression and protein levels in muscle and/or blood.
Time Frame: Baseline and after 2-weeks of supplementation
|
The study will determine whether markers of inflammation in serum (e.g.
C-reactive protein and cytokines) or blood mononuclear cells are decreased by the nutritional supplement.
Blood will be drawn before and after periods of supplementation.
The groups will be compared for protein and gene expression levels.
The study will also determine whether supplementation affects muscle expression of genes associated with inflammation or tissue growth and remodeling.
Muscle biopsies will be collected before and after two weeks of supplementation.
|
Baseline and after 2-weeks of supplementation
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Richard Dennis, PhD, Central Arkansas Veterans Healthcare System
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 391351
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sarcopenia
-
University of Texas at AustinNot yet recruitingExercise Training and SarcopeniaUnited States
-
Centre Hospitalier Universitaire DijonCompleted
-
Creighton UniversityUniversity of NebraskaRecruiting
-
University Hospital, CaenCompleted
-
University of NottinghamUniversity of OxfordRecruitingMuscle Atrophy | Age-Related SarcopeniaUnited Kingdom
-
Tufts UniversityNational Institute on Aging (NIA)CompletedMuscle Loss | Age-Related SarcopeniaUnited States
-
China Medical University HospitalCompleted
-
King's College LondonCo-sponsor: Guy's and St Thomas' NHS Foundation TrustCompletedFrailty | Sarcopenia | Age-Related SarcopeniaUnited Kingdom
-
Norwegian School of Sport SciencesOslo University HospitalNot yet recruitingHealthy Aging | Testosterone Deficiency | Age-Related Sarcopenia
-
Ningbo Medical Center Lihuili HospitalCompletedHemodialysis Patients With SarcopeniaChina
Clinical Trials on Muscle Armor Supplement
-
VA Office of Research and DevelopmentUniversity of ArkansasCompletedSarcopenia | Aging | Immune FunctionUnited States
-
Texas Christian UniversityCompleted
-
Wake Forest University Health SciencesWithdrawnMuscle Weakness | ICU-acquired WeaknessUnited States
-
Ministry of Science and Technology, IndiaUnknownPulmonary TuberculosisIndia
-
FEMPHARMA Kft.CompletedUrinary IncontinenceHungary
-
Sun Yat-sen UniversityWest China Hospital; Second Affiliated Hospital, School of Medicine, Zhejiang...Recruiting
-
European Organisation for Research and Treatment...Completed
-
University of California, DavisUniversity of British Columbia; Khon Kaen University; USDA, Western Human Nutrition... and other collaboratorsCompletedDiarrheaLao People's Democratic Republic
-
Texas Tech UniversityEHP LabsCompletedBody Weight Changes | Body Composition Changes | Anthropometric Changes | Metabolism Changes | Hemodynamic ChangesUnited States
-
Universidade Federal do AmazonasCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.; Hospital Universitario... and other collaboratorsCompletedOverweight | HypercholesterolemiaBrazil